Skip to main content

Advertisement

SpringerLink
Log in

The present and future of transplant organ shortage: some potential remedies

  • Review
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Transplantation remains the modality of choice for patients with end stage renal disease (ESRD). However, while there has been a steady rise in the number of patients with ESRD the supply of donors (combine living and deceased) has fallen far behind the need, resulting in an increasing number of qualified patients remaining on the wait-list, and thousands being removed from the list every year because of death or becoming too sick for transplantation. This has also fed to transplant tourism around the world. Several countries have implemented a variety of policies to overcome their organ shortage that are presented in this article. There is an urgent need for developing policies geared to the cultural norms of different societies and universally accepted ethical principles to remedy this public health issue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. USRDS (2017) Annual data report. Accessed in August 31, 2018. https://www.usrds.org/adr.aspx. 2017; Available from: https://www.usrds.org/adr.aspx

  2. Organ Procurement and transplantation network-national data (2018) Accessed in August 31, 2018. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/#

  3. United Network for Organ Sharing (2018) Accessed in August 31, 2018. https://unos.org/data/

  4. US Department of Justice, Drug Enforcement Administration (2018) Diversion control division—opioid addiction resources for dea registered practitioners—March 16, 2018. DEA_DCD@public.govdelivery.com

  5. National Institute on Drug Abuse—overdose death rates (revised in September 2017).  Accessed in March 23, 2018. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates

  6. Rodrigue JR, Schold JD, Mandelbrot DA (2013) The decline in living kidney donation in the united states: random variation or cause for concern? Transplantation 96(9):767–773

    Article  PubMed  Google Scholar 

  7. Kidney Allocation system—professional education—OPTN. Accesed in March 1, 2018. https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf

  8. Muzaale AD et al (2014) Risk of end-stage renal disease following live kidney donation. JAMA 311(6):579–586

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Mjoen G et al (2014) Long-term risks for kidney donors. Kidney Int 86(1):162–167

    Article  PubMed  Google Scholar 

  10. Grams ME, Garg AX, Lentine KL (2016) Kidney-failure risk projection for the living kidney-donor candidate reply. N Engl J Med 374(21):2094–2095

    PubMed  Google Scholar 

  11. OPTN/SRTR 2016 annual data report: kidney. Accessed in March 27, 2018. https://srtr.transplant.hrsa.gov/annual_reports/Default.aspx

  12. Khamash HA, Gaston RS (2008) Transplant tourism: a modern iteration of an ancient problem. Curr Opin Organ Transplant 13(4):395–399

    Article  PubMed  Google Scholar 

  13. Havoscope: Global Black Market Information. Accessed in April 2, 2018. https://www.havocscope.com/biggest-consumers-of-illegal-organs/

  14. Shimazono Y (WHO December 2007) The state of the international organ trade: a provisional picture based on integration of available information. Accessed in November 19, 2013. http://www.who.int/bulletin/volumes/85/12/06-039370/en/

  15. Organ trafficking prices and kidney transplant sales (2018). Accessed in August 30, 2018. https://www.havocscope.com/black-market-prices/organs-kidneys/

  16. Gill J et al (2008) Transplant tourism in the United States: a single-center experience. Clin J Am Soc Nephrol 3(6):1820–1828

    Article  PubMed  PubMed Central  Google Scholar 

  17. Prasad GV et al (2006) Outcomes of commercial renal transplantation: a Canadian experience. Transplantation 82(9):1130–1135

    Article  PubMed  Google Scholar 

  18. Merion RM et al (2005) Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 294(21):2726–2733

    Article  CAS  PubMed  Google Scholar 

  19. Ruiz-Ramon P, Hunsicker L, Steiner RW (ed) (2004) Educating, evaluating, and selecting living kidney donors, 35–49 © 2004 Kluwer Academic Publishers. The Netherlands. ISBN-13: 978-1402012716  

  20. The 2016 USRDS annual data report. Volume 2, chapter 7—transplantation. Accessed in March 23, 2018. https://www.usrds.org/2016/view/Default.aspx

  21. Meier-Kriesche HU, Kaplan B (2002) Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 74(10):1377–1381

    Article  PubMed  Google Scholar 

  22. Roger WE, Terasaki P, Barry Jacob’s Testimonies (1984) Hearings before the subcommittee on health and the environment of the committee on energy and commerce, house of representatives. In: 98th Congress, 1st session, on H.R. bill 4080. Serial no. 98–70, 50–72:59. Also see a related article in New York Times (1983). https://www.nytimes.com/1983/09/24/us/buying-of-kidneys-of-poor-attacked.html

  23. Organ procurement and transplantation network (OPTN) Data: data on donation and transplantation in 2017. Accessed in August 31, 2018. http://www.aopo.org/related-links-data-on-donation-and-transplantation/. 2017

  24. Sheehy E et al (2003) Estimating the number of potential organ donors in the United States. N Engl J Med 349(7):667–674

    Article  PubMed  Google Scholar 

  25. Al Sebayel M et al (2014) Donor organ shortage crisis: a case study review of a financial incentive-based system. Transplant Proc 46(6):2030–2035

    Article  CAS  PubMed  Google Scholar 

  26. Boulware LE et al (2006) Public attitudes toward incentives for organ donation: a national study of different racial/ethnic and income groups. Am J Transplant 6(11):2774–2785

    Article  CAS  PubMed  Google Scholar 

  27. Chkhotua A (2012) Incentives for organ donation: pros and cons. Transplant Proc 44(6):1793–1794

    Article  CAS  PubMed  Google Scholar 

  28. Fisher JS et al (2015) Between Scylla and Charybdis: charting an ethical course for research into financial incentives for living kidney donation. Am J Transplant 15(5):1180–1186

    Article  CAS  PubMed  Google Scholar 

  29. Harris CE, Alcorn SP (2001) To solve a deadly shortage: economic incentives for human organ donation. Issues Law Med 16(3):213–233

    CAS  PubMed  Google Scholar 

  30. Matas AJ (2006) Why we should develop a regulated system of kidney sales: a call for action! Clin J Am Soc Nephrol 1(6):1129–1132

    Article  PubMed  Google Scholar 

  31. Omar F, Tufveson G, Welin S (2010) Compensated living kidney donation: a plea for pragmatism. Health Care Anal 18(1):85–101

    Article  PubMed  Google Scholar 

  32. Matas A et al (2012) A realistic proposal–incentives may increase donation–we need trials now! Am J Transplant 12(7):1957–1958

    Article  CAS  PubMed  Google Scholar 

  33. Matas AJ (2013) A regulated system of incentives for living kidney donation: why can’t we agree to do a trial? Clin Transplant 26:227–234

    Google Scholar 

  34. Matas AJ, Hays RE (2014) A regulated system of incentives for living kidney donation: it is time for opposing groups to have a meaningful dialogue! Am J Transplant 14(8):1944–1945

    Article  CAS  PubMed  Google Scholar 

  35. Salomon DR et al (2015) AST/ASTS workshop on increasing organ donation in the United States: creating an “arc of change” from removing disincentives to testing incentives. Am J Transplant 15(5):1173–1179

    Article  CAS  PubMed  Google Scholar 

  36. Working Group on Incentives for Living, D et al (2012) Incentives for organ donation: proposed standards for an internationally acceptable system. Am J Transplant 12(2):306–312

    Article  Google Scholar 

  37. Abouna GM (2008) Organ shortage crisis: problems and possible solutions. Transplant Proc 40(1):34–38

    Article  CAS  PubMed  Google Scholar 

  38. Bastani B (2015) The worsening transplant organ shortage in USA; desperate times demand innovative solutions. J Nephropathol 4(4):105–109

    PubMed  PubMed Central  Google Scholar 

  39. Bastani B (2016) It’s time to reward the gift of life. J Nephropathol 5(3):88–89

    Article  PubMed  PubMed Central  Google Scholar 

  40. Yacoubian AA, Dargham RA, Khauli RB (2018) A review of the possibility of adopting financially driven live donor kidney transplantation: review. Int Braz J Urol 44(6):1071–1080

    Article  PubMed  PubMed Central  Google Scholar 

  41. Gaston RS et al (2006) Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant 6(11):2548–2555

    Article  CAS  PubMed  Google Scholar 

  42. Bastani B, Fry-Revere S (2015) A practical solution that bypasses the altruism versus incentives debate. Int Urol Nephrol 47(9):1515–1517

    Article  PubMed  Google Scholar 

  43. Delmonico FL (2016) Point: living organ donation should elicit care for the donor and be a financially neutral act. Reported in January 24, 2016. http://www.insidesources.com/category/politics/

  44. Tushla L et al (2015) Living-donor kidney transplantation: reducing financial barriers to live kidney donation-recommendations from a consensus conference. Clin J Am Soc Nephrol 10(9):1696–1702

    Article  PubMed  PubMed Central  Google Scholar 

  45. Poor people can’t even afford to donate kidneys (2014). Reported in July 17, 2014. https://www.science20.com/print/140821

  46. Gill J, Dong J, Gill J (2015) Population income and longitudinal trends in living kidney donation in the United States. J Am Soc Nephrol 26(1):201–207

    Article  PubMed  Google Scholar 

  47. Klarenbach S, Garg AX, Vlaicu S (2006) Living organ donors face financial barriers: a national reimbursement policy is needed. CMAJ 174(6):797–798

    Article  PubMed  PubMed Central  Google Scholar 

  48. Rodrigue JR et al (2016) Direct and indirect costs following living kidney donation: findings from the KDOC study. Am J Transplant 16(3):869–876

    Article  CAS  PubMed  Google Scholar 

  49. Larson DB et al (2019) Financial burden associated with time to return to work after living kidney donation. Am J Transplant 19(1):204–207

    Article  PubMed  Google Scholar 

  50. Morrison J (2016) It’s time to treat organ donors with respect they deserve. The Washington post-in theory (Opinion). Reported in January 1, 2016. https://www.washingtonpost.com/news/in-theory/wp/2016/01/01/its-time-to-treat-organ-donors-with-the-respect-they-deserve/

  51. Matas AJ, Schnitzler M, Daar AS (2004) Payment for living kidney donors (vendors) is not an abstract ethical discussion occurring in a vacuum. Am J Transplant 4(8):1380–1381

    Article  PubMed  Google Scholar 

  52. Fry-Revere S (2018) Solving the organ shortage by giving living organ donors what they deserve. J Hos Ethics 5(1):11–20

    Google Scholar 

  53. IRODaT (International Registry in Organ Donation and Transplantation) (2017) Final numbers 2016. Accessed in December 2017. WWW.irodat.org

  54. Ghods AJ, Savaj S (2006) Iranian model of paid and regulated living-unrelated kidney donation. Clin J Am Soc Nephrol 1(6):1136–1145

    Article  PubMed  Google Scholar 

  55. Mahdavi-Mazdeh M (2012) The Iranian model of living renal transplantation. Kidney Int 82(6):627–634

    Article  PubMed  Google Scholar 

  56. Hamidian Jahromi A, Fry-Revere S, Bastani B (2015) A revised Iranian model of organ donation as an answer to the current organ shortage crisis. Iran J Kidney Dis 9(5):354–360

    PubMed  Google Scholar 

  57. Fry-Revere S (2014) The kidney sellers: a journey of discovery in Iran. Carolina Academic Press, Durham North Carolina. ISBN-13: 978-1611635126  

  58. Bastani B (2018) The Iranian model as a potential solution for kidney shortage crisis. J Nephropathol 7(4):220–223

    Article  Google Scholar 

  59. Ghahramani N (2016) Paid living donation and growth of deceased donor programs. Transplantation 100(6):1165–1169

    Article  PubMed  Google Scholar 

  60. Islamic Republic of Iran Parliament (2000) Deceased or brain dead patients organ transplantation Act. H/24804-T/9929, June 4, 2000

  61. Simforoosh NBA, Tabibi A, Nadjafi-Semnani M (2018) Living unrelated kidney transplantation: Does it prevent deceased donor kidney transplantation growth? Transplantation 102(Supplement 7S-1)

  62. Khoddami-Vishteh HR et al (2010) Causes and follow-up outcomes of brain dead patients in Shahid Beheshti University of Medical Sciences Hospitals. Pejouhandeh 15(4):171–178 (in Persian)

    Google Scholar 

  63. Einollahi B et al (2007) Deceased-donor kidney transplantation in Iran: trends, barriers and opportunities. Indian J Med Ethics 4(2):70–72

    PubMed  Google Scholar 

  64. Mojtabaee M et al (2018) Update on causes of family refusal for organ donation and the related factors: reporting the changes over 6 Years. Transplant Proc 50(1):10–13

    Article  CAS  PubMed  Google Scholar 

  65. Massie AB et al (2017) Quantifying postdonation risk of ESRD in living kidney donors. J Am Soc Nephrol 28(9):2749–2755

    Article  PubMed  PubMed Central  Google Scholar 

  66. Matas AJ et al (2018) Causes and timing of end-stage renal disease after living kidney donation. Am J Transplant 18(5):1140–1150

    Article  PubMed  Google Scholar 

  67. Matas AJ, Hays RE, Ibrahim HN (2017) A case-based analysis of whether living related donors listed for transplant share ESRD causes with their recipients. Clin J Am Soc Nephrol 12(4):663–668

    Article  PubMed  PubMed Central  Google Scholar 

  68. Ravitsky V (2013) Incentives for postmortem organ donation: ethical and cultural considerations. J Med Ethics 39(6):380–381

    Article  PubMed  Google Scholar 

  69. Arnold R et al (2002) Financial incentives for cadaver organ donation: an ethical reappraisal. Transplantation 73(8):1361–1367

    Article  PubMed  Google Scholar 

  70. Delmonico FL et al (2002) Ethical incentives–not payment–for organ donation. N Engl J Med 346(25):2002–2005

    Article  PubMed  Google Scholar 

  71. Wu X, Fang Q (2013) Financial compensation for deceased organ donation in China. J Med Ethics 39(6):378–379

    Article  PubMed  Google Scholar 

  72. National Bureau of Statistics of China-China’s Economy Achieved a Stabilized and Accelerated Development in the Year of 2012. Accessed 9 Mar 2013. http://www.stats.gov.cn/was40/gjtjj_en_detail.jsp?searchword=Disposable+income&channelid=9528&record=3. January 18, 2013

  73. Lam WA, McCullough LB (2000) Influence of religious and spiritual values on the willingness of Chinese-Americans to donate organs for transplantation. Clin Transplant 14(5):449–456

    Article  CAS  PubMed  Google Scholar 

  74. Naghavi M et al (2009) Adverse health outcomes of road traffic injuries in Iran after rapid motorization. Arch Iran Med 12(3):284–294

    PubMed  Google Scholar 

  75. World Health Ranking. Accessed in August 31, 2018. http://www.worldlifeexpectancy.com/cause-of-death/road-traffic-accidents/by-country/

  76. Broumand M, Parsapoor A, Asghari F (2012) Public opinion of organ donation: a survey in Iran. Clin Transplant 26(5):E500–E504

    Article  PubMed  Google Scholar 

  77. Lavee J et al (2010) A new law for allocation of donor organs in Israel. Lancet 375(9720):1131–1133

    Article  PubMed  Google Scholar 

  78. Lavee J et al (2013) Preliminary marked increase in the national organ donation rate in Israel following implementation of a new organ transplantation law. Am J Transplant 13(3):780–785

    Article  CAS  PubMed  Google Scholar 

  79. The Brain-Respiratory Death Law 5768-2008. Israeli Book of Laws. Accessed October 5, 2012. http://www.knesset.gov.il/Laws/Data/law/2144/2144.pdf

  80. The Organ Transplantation Law 5768-2008. Israeli book of laws. English translation. Accessed October 5, 2012. http://www.declarationofistanbul.org/index.php?option=com_content&view=article&id=267:israel-transplant-law-organ-transplant-act-2008&catid=83:legislation&Itemid=130

  81. Lavee J (2013) Ethical amendments to the Israeli organ transplant law. Am J Transplant 13(6):1614

    Article  CAS  PubMed  Google Scholar 

  82. Quigley M, Wright L, Ravitsky V (2012) Organ donation and priority points in Israel: an ethical analysis. Transplantation 93(10):970–973

    Article  PubMed  Google Scholar 

  83. H.R. 6448—Organ Donation Clarification Act of 2018. https://www.congress.gov/bill/115th-congress/house-bill/6448/text

Download references

Funding

No funding.

Author information

Authors and Affiliations

  1. Division of Nephrology, Saint Louis University Hospital, Saint Louis University School of Medicine, 3635 Vista Avenue, Saint Louis, MO, 63110, USA

    Bahar Bastani

Authors
  1. Bahar Bastani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bahar Bastani.

Ethics declarations

Conflict of interest

The author declare that they have no competing interests.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bastani, B. The present and future of transplant organ shortage: some potential remedies. J Nephrol 33, 277–288 (2020). https://doi.org/10.1007/s40620-019-00634-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-019-00634-x

Keywords

Search

Navigation